Powered by

Predictive Oncology's Skyline Medical Division Expands Its Asian Market Share with First-Ever Orders of STREAMWAY Systems in India

Aug 06, 2019 - GlobeNewswire

MINNEAPOLIS, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology, Inc. (Nasdaq: POAI) ("Predictive Oncology" or "the Company"), today announced its Skyline Medical division has received its first order from India for four machines to be sold to local hospitals.

"The sale of these four STREAMWAY units in India marks our entry into that country, and is an exciting milestone in our continued market expansion," commented Dr. Carl Schwartz, chief executive officer of Predictive Oncology.

The Indian healthcare industry is estimated to be more than $100 billion with the nation's medical device industry valued at more than $6 billi...